NCT00220883

Completed

Electrogastrogram (EGG) Reproducibility Study: EEG Readings ...

Temple University Source

Compare

Other study identifiers

Sponsor study identifier

TU4687

Study Type

observational

Estimated enrollment

40

Locations

1 country

Sites

1

Timeline

Study Start

August 2005

Actual (reported)

Primary Completion

August 2006

Actual (reported)

Study Completion

September 2006

Actual (reported)

Brief Summary

The primary objective of this study is to determine whether EGG readings obtained from both normal subjects and dyspeptic patients are reproducible from one EGG recording to another on a different day. The secondary objective of this study is to determine whether the EGG readings are analyzed and diagnosed consistently when reviewed and compared by multiple blinded readers when the same tracing is reviewed.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Estimated enrollment: 40 participants
Study completion date: September 2006
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
August 2005
Actual (reported)
First Submitted
September 19, 2005
Actual (reported)
First Posted
September 22, 2005
Actual (reported)
Primary Completion
August 2006
Actual (reported)
Study Completion
September 2006
Actual (reported)

Last Updated: August 17, 2020
Status Verified: August 2020
Last Update Submitted: August 13, 2020

Conditions

Functional Dyspepsia

Keywords

Functional DyspepsiaElectrogastrography

Eligibility Criteria

Age18 Years - 72 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Male or female patients who are 18 years of age to 72 years of age.
Normal healthy subjects with no signs or symptoms of gastrointestinal discomfort.

You may not qualify if:

Patients will not be included in this study if they are:
\< 18 years of age or \>72 years of age

Sponsors & Collaborators

Temple University
Otherlead

Study Sites (1)

Temple University School of Medicine

Philadelphia, Pennsylvania, 19140, United States

Study Officials

Henry P Parkman, MD
Temple University
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 19, 2005

First Posted

September 22, 2005

Study Start

August 2005

Actual (reported)

Primary Completion

August 2006

Actual (reported)

NCT00333372

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Phase 2Completed

NCT01052896

Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition

Phase 3Withdrawn

NCT02484248

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

Phase 3Recruiting

NCT01240096

Mirtazapine Versus Placebo in Functional Dyspepsia

Phase 4Completed

NCT03884270

Functional Dyspepsia Hypnosis

Not ApplicableCompleted

NCT05655819

A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia

Phase 1/2Completed

Subjects with known gastrointestinal or liver cancers, pancreaticobiliary tract diseases, active peptic ulcer disease or uncontrolled lactose intolerance.

Subjects with cardiovascular, pulmonary disorders, or subjects with diabetes mellitus, a malignancy or who are known to be HIV positive.

Subjects with a history of gastric, intestinal or colonic resections. Subjects who are at less than a three month status for either: post appendectomy, cholecystectomy, or hysterectomy with or without oophorectomy.

Subjects who are unable to give informed consent or adequately express their subjective complaints.

Subjects who abuse drugs or alcohol.

Female subjects who are pregnant.

For functional dyspepsia patients:

Male or female patients who are 18 to 72 years of age.

Patients who present with varying gastric complaints of discomfort

Patients who meet all Rome II criteria for functional dyspepsia (see Rome II criteria checklist)

Concomitant medications are allowed during the study period.

Contact the study team to confirm eligibility.

Study Completion

September 2006

Actual (reported)

Last Updated

August 17, 2020

Record last verified: 2020-08

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00220883
Data provider: ClinicalTrials.gov
Source updated: 2020-08-17
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:06 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Study Design

Study Record Dates

Source record

Locations